H3L Stock Overview
ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for chronic condition management.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ClouDr Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.40 |
| 52 Week High | HK$1.08 |
| 52 Week Low | HK$0.27 |
| Beta | 0 |
| 1 Month Change | 30.52% |
| 3 Month Change | -37.19% |
| 1 Year Change | -62.78% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -77.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| H3L | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -2.4% | 2.1% | 2.0% |
| 1Y | -62.8% | -1.0% | 5.9% |
Return vs Industry: H3L underperformed the German Healthcare industry which returned -1.1% over the past year.
Return vs Market: H3L underperformed the German Market which returned 6% over the past year.
Price Volatility
| H3L volatility | |
|---|---|
| H3L Average Weekly Movement | 12.9% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: H3L's share price has been volatile over the past 3 months.
Volatility Over Time: H3L's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 1,522 | Ming Kuang | www.cloudr.cn |
ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for chronic condition management. Its in-hospital solution provides chronic condition management solution to hospitals including hospital SaaS and proprietary artificial intelligence of things devices, and value added solutions, such as provision of medical devices and consumables. The company offers pharmacy solution, which includes subscription solution of pharmacy SaaS and the value added solution to provide pharmaceuticals to pharmacies through leveraging data insights generated by SaaS products.
ClouDr Group Limited Fundamentals Summary
| H3L fundamental statistics | |
|---|---|
| Market cap | €239.17m |
| Earnings (TTM) | -€41.50m |
| Revenue (TTM) | €474.03m |
0.5x
P/S Ratio-5.8x
P/E RatioIs H3L overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| H3L income statement (TTM) | |
|---|---|
| Revenue | CN¥3.69b |
| Cost of Revenue | CN¥2.78b |
| Gross Profit | CN¥909.38m |
| Other Expenses | CN¥1.23b |
| Earnings | -CN¥323.06m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.55 |
| Gross Margin | 24.64% |
| Net Profit Margin | -8.75% |
| Debt/Equity Ratio | 13.3% |
How did H3L perform over the long term?
See historical performance and comparison